These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6763197)

  • 1. [Cardiovascular effects of prostacyclin].
    Chaignon M; Guelpa G; Lucsko M; Guédon J
    Nouv Presse Med; 1982 Dec; 11(50):3717-21. PubMed ID: 6763197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
    Dusting GJ; Vane JR
    Circ Res; 1980 Jun; 46(6 Pt 2):I183-7. PubMed ID: 6991150
    [No Abstract]   [Full Text] [Related]  

  • 4. The general pharmacology of prostacyclin (pgi2, pgx): a new prostaglandin especially activity on the cardiovascular system.
    Weeks JR
    Pol J Pharmacol Pharm; 1978; 30(2-3):215-21. PubMed ID: 97642
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system.
    Weeks JR
    Acta Biol Med Ger; 1978; 37(5-6):707-14. PubMed ID: 369253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
    El-Haroun H; Bradbury D; Clayton A; Knox AJ
    Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of prostacyclin on blood circulatory indices in the rat].
    Markov KhM; Pinelis VG
    Patol Fiziol Eksp Ter; 1982; (2):35-8. PubMed ID: 7045784
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin effects on the blood pressure responses to norepinephrine in rats treated with aspirin or indomethacin.
    Carmignani M; Marchetti P; Caprino L
    Artery; 1980; 8(1):90-5. PubMed ID: 7000045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems.
    Dusting GJ; Moncada S; Vane JR
    Prog Cardiovasc Dis; 1979; 21(6):405-30. PubMed ID: 375296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin I2 (prostacyclin).
    Kelton JG; Blajchman MA
    Can Med Assoc J; 1980 Jan; 122(2):175-9. PubMed ID: 6988063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin.
    Weksler BB
    Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prostacyclin and 9a, 11a-epoxymethanoprostaglandin H2 on calcium and magnesium fluxes and tension development in canine intralobar pulmonary arteries and veins.
    Greenberg S
    J Pharmacol Exp Ther; 1981 Nov; 219(2):326-37. PubMed ID: 7026765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pharmacology and clinical aspects of the prostanoids].
    Ambrosioni E; Degli Esposti D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():59S-65S. PubMed ID: 8117524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
    Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of PGI2 in patients with ischemic heart disease--coronary dilator action of prostacyclin and dissolution of coronary spasms observed in coronary angiography].
    Saito S; Tsuzi M; Tamura Y; Tomobe K; Tokutake E; Yumikura S; Hibiya K; Yamamoto M; Ichikawa M; Honda M; Ozawa Y; Hatano M
    Kokyu To Junkan; 1982 Oct; 30(10):1033-8. PubMed ID: 6760309
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2-derived prostacyclin modulates vascular remodeling.
    Rudic RD; Brinster D; Cheng Y; Fries S; Song WL; Austin S; Coffman TM; FitzGerald GA
    Circ Res; 2005 Jun; 96(12):1240-7. PubMed ID: 15905461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostaglandins and the cardiovascular system].
    Maclouf J
    Ann Cardiol Angeiol (Paris); 1983 Nov; 32(7):435-8. PubMed ID: 6362546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.